Namiko Matsumoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Namiko Matsumoto has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Toru Yamashita
Department of Neurology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan
13 shared publications Nozomi Hishikawa
Department of Neurology Graduate School of Medicine Dentistry and Pharmaceutical Sciences Okayama University Okayama Japan
11 shared publicationsMami Takemoto
Department of Neurology Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Okayama Japan
10 shared publications- Yuko Kawahara
Department of Neurology Graduate School of Medicine Dentistry and Pharmaceutical Sciences Okayama University Okayama Japan
9 shared publications - Kota Sato
Department of Neurology Graduate School of Medicine Dentistry and Pharmaceutical Sciences Okayama University Okayama Japan
8 shared publications Yasuyuki Ohta
Departments of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan
7 shared publications
Latest Publications
- 1 September 2022
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 10 (5) , 252-254
A case of successful renal transplantation of Charcot-Marie-Tooth disease associated with FSGS due to mutation of the INF2 gene
- 1 September 2022
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 10 (5) , 252-254
A case of successful renal transplantation of Charcot-Marie-Tooth disease associated with FSGS due to mutation of the INF2 gene
- Open Access
Binary Iterative Hard Thresholding Converges with Optimal Number of Measurements for 1-Bit Compressed Sensing
Compressed sensing has been a very successful high-dimensional signal acquisition and recovery technique that relies on linear operations. However, the actual measurements of signals have to be quantized before storing or processing. 1(One)-bit compressed sensing is a heavily quantized version of compressed sensing, where each linear measurement of a signal is reduced to just one bit: the sign of the measurement. Once enough of such measurements are collected, the recovery problem in 1-bit compressed sensing aims to find the original signal with as much accuracy as possible. The recovery problem is related to the traditional "halfspace-learning" problem in learning theory. For recovery of sparse vectors, a popular reconstruction method from 1-bit measurements is the binary iterative hard thresholding (BIHT) algorithm. The algorithm is a simple projected sub-gradient descent method, and is known to converge well empirically, despite the nonconvexity of the problem. The convergence property of BIHT was not theoretically justified, except with an exorbitantly large number of measurements (i.e., a number of measurement greater than $\max\{k^{10}, 24^{48}, k^{3.5}/\epsilon\}$, where $k$ is the sparsity, $\epsilon$ denotes the approximation error, and even this expression hides other factors). In this paper we show that the BIHT algorithm converges with only $\tilde{O}(\frac{k}{\epsilon})$ measurements. Note that, this dependence on $k$ and $\epsilon$ is optimal for any recovery method in 1-bit compressed sensing. With this result, to the best of our knowledge, BIHT is the only practical and efficient (polynomial time) algorithm that requires the optimal number of measurements in all parameters (both $k$ and $\epsilon$). This is also an example of a gradient descent algorithm converging to the correct solution for a nonconvex problem, under suitable structural conditions.Open AccessBinary Iterative Hard Thresholding Converges with Optimal Number of Measurements for 1-Bit Compressed Sensing
Compressed sensing has been a very successful high-dimensional signal acquisition and recovery technique that relies on linear operations. However, the actual measurements of signals have to be quantized before storing or processing. 1(One)-bit compressed sensing is a heavily quantized version of compressed sensing, where each linear measurement of a signal is reduced to just one bit: the sign of the measurement. Once enough of such measurements are collected, the recovery problem in 1-bit compressed sensing aims to find the original signal with as much accuracy as possible. The recovery problem is related to the traditional "halfspace-learning" problem in learning theory. For recovery of sparse vectors, a popular reconstruction method from 1-bit measurements is the binary iterative hard thresholding (BIHT) algorithm. The algorithm is a simple projected sub-gradient descent method, and is known to converge well empirically, despite the nonconvexity of the problem. The convergence property of BIHT was not theoretically justified, except with an exorbitantly large number of measurements (i.e., a number of measurement greater than $\max\{k^{10}, 24^{48}, k^{3.5}/\epsilon\}$, where $k$ is the sparsity, $\epsilon$ denotes the approximation error, and even this expression hides other factors). In this paper we show that the BIHT algorithm converges with only $\tilde{O}(\frac{k}{\epsilon})$ measurements. Note that, this dependence on $k$ and $\epsilon$ is optimal for any recovery method in 1-bit compressed sensing. With this result, to the best of our knowledge, BIHT is the only practical and efficient (polynomial time) algorithm that requires the optimal number of measurements in all parameters (both $k$ and $\epsilon$). This is also an example of a gradient descent algorithm converging to the correct solution for a nonconvex problem, under suitable structural conditions. - 1 March 2022
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 10 (2) , 98-101
A case of a heterozygous ABCC6 mutation showing recurrent ischemic strokes and intracranial hemorrhages
- 1 March 2022
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 10 (2) , 98-101
A case of a heterozygous ABCC6 mutation showing recurrent ischemic strokes and intracranial hemorrhages
- 17 August 2021
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 9 (6) , 474-477
Successful treatment of anti‐GAD antibody‐associated autoimmune cerebellar ataxia with combined immunotherapies
- 17 August 2021
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 9 (6) , 474-477
Successful treatment of anti‐GAD antibody‐associated autoimmune cerebellar ataxia with combined immunotherapies
- 17 August 2021
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 9 (6) , 470-473
A case of rheumatoid meningoencephalitis induced by pembrolizumab
- 17 August 2021
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 9 (6) , 470-473
A case of rheumatoid meningoencephalitis induced by pembrolizumab
- 27 May 2021
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 9 (4) , 346-348
The first case of chronic inflammatory demyelinating polyneuropathy after transsexualism and continuous testosterone administration
- 27 May 2021
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 9 (4) , 346-348
The first case of chronic inflammatory demyelinating polyneuropathy after transsexualism and continuous testosterone administration
- 23 February 2021
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 9 (3) , 218-222
Positive baseline behavioral and psychological symptoms of dementia predict a subsequent cognitive impairment in cognitively normal population
Background: Because behavioral and psychological symptoms of dementia (BPSD) are sometimes prodromal symptoms of dementia, it is important to investigate the relationship between BPSD and subsequent cognitive decline.Methods: We examined the cognitive and affective functions of 76 cognitively normal subjects at initial assessment (baseline) and 1‐year follow‐up. Cognitive function was assessed using clinical dementia rating (CDR) and Mini‐Mental State Examination (MMSE), and affective function was assessed using Abe's BPSD score (ABS) and mild behavioral impairment (MBI).Results: Although there was no change in MMSE, ABS, or MBI after 1 year, the mean CDR score of 0 at baseline increased to 0.1 ± 0.2 at 1‐year follow‐up (**P < 0.01 vs baseline). No significant change in MMSE was found in both baseline ABS and MBI positive‐ or negative‐groups. In contrast, baseline MBI‐dependent CDR change showed a 13.2% of worsening in MBI‐negative subjects and a 62.5% of MBI‐positive subjects (††P < 0.01), but ABS not.Conclusion: The present data indicate that positive baseline BPSD with MBI was closely related to a subsequent CDR exacerbation. Examining BPSD may be useful for screening cognitively normal population for subsequent dementia development in local communities.
- 23 February 2021
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 9 (3) , 218-222
Positive baseline behavioral and psychological symptoms of dementia predict a subsequent cognitive impairment in cognitively normal population
Background: Because behavioral and psychological symptoms of dementia (BPSD) are sometimes prodromal symptoms of dementia, it is important to investigate the relationship between BPSD and subsequent cognitive decline.Methods: We examined the cognitive and affective functions of 76 cognitively normal subjects at initial assessment (baseline) and 1‐year follow‐up. Cognitive function was assessed using clinical dementia rating (CDR) and Mini‐Mental State Examination (MMSE), and affective function was assessed using Abe's BPSD score (ABS) and mild behavioral impairment (MBI).Results: Although there was no change in MMSE, ABS, or MBI after 1 year, the mean CDR score of 0 at baseline increased to 0.1 ± 0.2 at 1‐year follow‐up (**P < 0.01 vs baseline). No significant change in MMSE was found in both baseline ABS and MBI positive‐ or negative‐groups. In contrast, baseline MBI‐dependent CDR change showed a 13.2% of worsening in MBI‐negative subjects and a 62.5% of MBI‐positive subjects (††P < 0.01), but ABS not.Conclusion: The present data indicate that positive baseline BPSD with MBI was closely related to a subsequent CDR exacerbation. Examining BPSD may be useful for screening cognitively normal population for subsequent dementia development in local communities.
- 1 July 2020
- Published by Elsevier in Brain Research
- Vol. 1739, 146831
Up-regulation of sphingosine-1-phosphate receptors and sphingosine kinase 1 in the peri-ischemic area after transient middle cerebral artery occlusion in mice
- 1 July 2020
- Published by Elsevier in Brain Research
- Vol. 1739, 146831
Up-regulation of sphingosine-1-phosphate receptors and sphingosine kinase 1 in the peri-ischemic area after transient middle cerebral artery occlusion in mice
- 30 May 2020
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 8 (5) , 313-316
A case of triple seronegative myasthenia gravis with Graves' disease ameliorated after the removal of enlarged thymus with elevated uptake in fluorine‐18 fluorodeoxyglucose positron emission tomography
We report on a 35‐year‐old woman who complained of myasthenia in ocular, bulbar, and limb muscles, but who was negative for antibodies against acetylcholine receptor, muscle‐specific kinase, or low‐density lipoprotein receptor‐related protein 4, accompanied by the suppression of thyroid‐stimulating hormone with elevated free T3 and free T4. Administration of edrophonium significantly ameliorated blepharoptosis, and electromyography revealed 13.9% waning after 3 Hz repetitive stimulation in the left accessory nerve. Thus, she was suspected of having triple seronegative myasthenia gravis or thyrotoxic myasthenia. She was remitted after the resection of her enlarged thymus with an elevated uptake in fluorine‐18 fluorodeoxyglucose positron emission tomography, suggesting an unknown autoimmune target that escaped detection by current autoantibody screens. Consequently, thymectomy may still be effective in patients with seronegative MG plus hyperthyroidism.
- 30 May 2020
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 8 (5) , 313-316
A case of triple seronegative myasthenia gravis with Graves' disease ameliorated after the removal of enlarged thymus with elevated uptake in fluorine‐18 fluorodeoxyglucose positron emission tomography
We report on a 35‐year‐old woman who complained of myasthenia in ocular, bulbar, and limb muscles, but who was negative for antibodies against acetylcholine receptor, muscle‐specific kinase, or low‐density lipoprotein receptor‐related protein 4, accompanied by the suppression of thyroid‐stimulating hormone with elevated free T3 and free T4. Administration of edrophonium significantly ameliorated blepharoptosis, and electromyography revealed 13.9% waning after 3 Hz repetitive stimulation in the left accessory nerve. Thus, she was suspected of having triple seronegative myasthenia gravis or thyrotoxic myasthenia. She was remitted after the resection of her enlarged thymus with an elevated uptake in fluorine‐18 fluorodeoxyglucose positron emission tomography, suggesting an unknown autoimmune target that escaped detection by current autoantibody screens. Consequently, thymectomy may still be effective in patients with seronegative MG plus hyperthyroidism.
- 20 December 2019
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 8 (2) , 92-95
A unique case with positive anti‐myelin oligodendrocyte glycoprotein antibody presenting multiple brain lesions
The accurate diagnosis of anti‐myelin oligodendrocyte glycoprotein (MOG) antibody‐associated diseases is sometimes challenging due to its various central nervous system (CNS) lesions. Here, we report a 22‐year‐old man with positive anti‐MOG antibody presenting multiple brain lesions including a brainstem tumefactive demyelinating lesion (TDL), cortical edematous lesions, and a periventricular white matter lesion. These variety of lesions made the diagnosis challenging, especially because TDL is quite rare among MOG antibody‐associated disease patients. The present case suggests the importance to check anti‐MOG antibody for patients presenting atypical multiple CNS lesions.
- 20 December 2019
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 8 (2) , 92-95
A unique case with positive anti‐myelin oligodendrocyte glycoprotein antibody presenting multiple brain lesions
The accurate diagnosis of anti‐myelin oligodendrocyte glycoprotein (MOG) antibody‐associated diseases is sometimes challenging due to its various central nervous system (CNS) lesions. Here, we report a 22‐year‐old man with positive anti‐MOG antibody presenting multiple brain lesions including a brainstem tumefactive demyelinating lesion (TDL), cortical edematous lesions, and a periventricular white matter lesion. These variety of lesions made the diagnosis challenging, especially because TDL is quite rare among MOG antibody‐associated disease patients. The present case suggests the importance to check anti‐MOG antibody for patients presenting atypical multiple CNS lesions.